Enhancing antitumor immunity perioperatively: a matter of timing, cooperation, and specificity.
Curtis
Jeffrey L
JL
Pulmonary and Critical Care Medicine Section, Medical Service, Department of Veterans Affairs Health Care System, Ann Arbor, MI 48105-2303, USA. jlcurtis@umich.edu
Punturieri
Antonello
A
D000818:Animals; D029721:Drosophila Proteins; D006801:Humans; D007107:Immune System / Q000502:physiology*; D007694:Killer Cells, Natural / Q000276:immunology / Q000378:metabolism; D007963:Leukocytes, Mononuclear / Q000276:immunology / Q000378:metabolism; D055666:Lipopeptides; D008264:Macrophages / Q000276:immunology / Q000378:metabolism; D008562:Membrane Glycoproteins / Q000276:immunology / Q000378:metabolism; D009369:Neoplasms / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D009842:Oligopeptides / Q000378:metabolism; D019990:Perioperative Care; D011956:Receptors, Cell Surface / Q000276:immunology / Q000378:metabolism; D051193:Toll-Like Receptors
D029721:Drosophila Proteins; D055666:Lipopeptides; D008562:Membrane Glycoproteins; D009842:Oligopeptides; D011956:Receptors, Cell Surface; D051193:Toll-Like Receptors; C106335:macrophage stimulatory lipopeptide 2